Molecular Diagnostics Global Market 2016 by Application, Region, Technology, Value, Analysis and Forecast to 2020

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

For more information about this report: http://www.reportsweb.com/global-molecular-diagnostics-market-2016-2020

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market. Asia-Pacific is expected to register the highest growth rate in expansion of molecular diagnostics in the coming years.

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market includes increasing clinical microbiological laboratories in developing nations, next generation sequencing, and increase in sale of point of care devices.

The report offers an in-depth analysis of the Global Molecular Diagnostics Market with focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding, Abbott Laboratories, Hologic Inc., and Qiagen have been covered in the report.

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001512683/sample

Table of Contents
1. Market Overview
2. Global In Vitro Diagnostics (IVD) Market
3. Global Molecular Diagnostics (MD) Market
4. Regional Market
5. Market Dynamics
6. Competitive Landscape
7. Company Profiles

7.1 Roche Holding
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Hologic Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Qiagen
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001512683/buying

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.